Creating smoke-free homes in Armenia and Georgia
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
This project offers a short, culturally adapted program to help families in Armenia and Georgia keep their homes smoke-free and lower children's and adults' exposure to secondhand smoke.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11266183 on NIH RePORTER |
What this research studies
You would be offered a brief program, adapted to local culture, that teaches practical steps families can take to make their homes smoke-free. The research team will work with local community coalitions already active in selected towns to deliver the program and support participating households. Staff will collect information over time about home smoking rules, children's and adults' exposure, and any changes in smoking behavior to see how well the program works in everyday settings. The study builds on a similar approach that was effective and cost‑effective in low‑income U.S. households.
Who could benefit from this research
Good fit: Ideal participants are households in selected communities in Armenia or Georgia where one or more people currently smoke and where children or nonsmoking adults live.
Not a fit: People who do not live in the study communities, who already have fully smoke‑free homes, or who are not willing to try home smoking changes are unlikely to benefit from this project.
Why it matters
Potential benefit: If successful, the program could lower secondhand smoke exposure for children and adults, help some smokers reduce or quit, and reduce future tobacco-related disease in these communities.
How similar studies have performed: A similar brief, theory‑based smoke‑free homes program proved effective, scalable, and cost‑effective in low‑income U.S. households, but it has not yet been widely tested in Armenia or Georgia.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Berg, Carla J — George Washington University
- Study coordinator: Berg, Carla J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.